Michelle Ashley, MSN/MPH, RN, OCN, CBCN, CN-BN, NCTTP, CTTS
RWJBarnabas Health System and Rutgers Cancer Institute of New Jersey, Somerset, NJAuthored Items
November 13, 2020 | November 2020 Vol 11, No 11
Early-stage and hormone receptor–positive breast cancers may need additional genomic testing to determine which patients need chemotherapy in addition to endocrine therapy.
Last modified: October 27, 2022